Back HIV Policy & Advocacy

HIV Policy & Advocacy

Bipartisan Representatives Launch Congressional HIV/AIDS Caucus

On September 15, 2011, a group of representatives announced the creation of a new legislative caucus focusing on HIV. The Congressional HIV/AIDS Caucus, which to date includes 59 members, both Democrats and Republicans, will advocate for more funding for HIV research, prevention, and treatment in the U.S. and abroad, including expansion of the number of people treated through PEPFAR.alt

Read more:

UK Safety Review Leads to Lifting Ban on Gay Blood Donors

A review by a UK safety advisory committee found that the type and timing of sexual activity -- not sexual orientation -- is the relevant risk factor for HIV transmission via donated blood, prompting health ministers in England, Scotland, and Wales to rescind the lifetime blanket ban on donation by men who have had sex with another man.

alt

Read more:

TAG Seeks Activists for AIDS Cure/HIV and Aging Advocacy

The Treatment Action Group (TAG) has issued a call for community activists interested in joining a new network advocating for increased support for research on HIV and aging and finding a cure. The initiative will kick off with congressional lobbying October 11-13. Travel scholarships are available, and the deadline to apply is September 2.alt

Read more:

Poorer Outcomes among HIV Patients on Public Insurance

Among HIV positive people who started antiretroviral therapy in the U.S. HOPS cohort, those who used public insurance such as Medicare or ADAP had more cardiovascular and liver disease and were more likely to die than individuals with private insurance, according to a report in the August 5, 2011, advance online edition of AIDS.alt

Read more:

ADAP Waiting List Exceeds 9000 for the First Time

The number of people on AIDS Drug Assistance Program (ADAP) waiting lists rose above 9000 for the first time ever, according to the most recent issue of The ADAP Watch, produced by the National Alliance of State and Territorial AIDS Directors (NASTAD). alt

 

Read more: